Clinical trials must wait to see if there is a significant difference in the infection rate of two groups, one given an experimental vaccine, the other a placebo. [AFP]
The head of the US Food and Drug Administration raised the possibility in an interview published Sunday that a future vaccine against the coronavirus might be given emergency approval before the end of trials designed to ensure its safety and effectiveness.